2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Respiratory Failure: new trials by email Literature Review of Respiratory Failure trials Research Report on Respiratory Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avoiding Neuromuscular Blockers to Reduce Complications Neuromuscular Blocking Agents, Anesthetic Adjuncts - Respiratory Failure, Respiratory Infection | Phase 4 | Terminated | Beth Israel Deaconess Medical Center | 3 | 2019-08-07 | 2026-06-04 |
| Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant Clinically prescribed direct acting antiviral (Mavyret or Epclusa) HCV treatment for 8 weeks - Respiratory Failure, Hepatitis C | Phase 4 | Terminated | Massachusetts General Hospital | 19 | 2019-02-05 | 2023-04-25 |
Respiratory Insufficiency (2) · Bronchial Spasm (1) · Hepatitis C (1) · Lung Diseases (1) · Pneumonia (1) · Pneumonia, Aspiration (1) · Pulmonary Atelectasis (1) · Respiratory Tract Infections (1)
Infections (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Blood-Borne Infections (1) · Bronchial Diseases (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Liver Diseases (1) · Lung Diseases (1) · RNA Virus Infections (1) · Virus Diseases (1)
Analgesics, Opioid (1) · Dexmedetomidine (1) · Ketamine (1) · Neuromuscular Blocking Agents (1) · Propofol (1) · Rocuronium (1) · glecaprevir and pibrentasvir (1) · sofosbuvir-velpatasvir drug combination (1)
Beth Israel Deaconess Medical Center (1) · Massachusetts General Hospital (1)
United States (2)
Maximilian S Schaefer, MD (1) · Raymond T Chung, MD (1)